A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/22/2006	EP1722778A1 Methods and compositions for the treatment of lipodystrophy
11/22/2006	EP1722762A2 Nanocell drug delivery system
11/22/2006	EP1722739A2 Keratin gel and the types 2, 4 and 6 of collagens of frog protein for topical use or for lamina preparation use, such as dressing or powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical
11/22/2006	EP1722645A1 Solubilized coq-10 and carnitine
11/22/2006	EP1558080A4 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
11/22/2006	EP1534320B1 Apolipoprotein l-i for the treatment of trypanosomal diseases
11/22/2006	EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
11/22/2006	EP1492553B1 Cg8327 and srm involved in the regulation of energy homeostasis
11/22/2006	EP1480998B1 Intermediates and methods for making heptapeptide oxytocin analogues
11/22/2006	EP1459738A4 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
11/22/2006	EP1424083B1 Diagnostic agent for pancreatic exocrine function
11/22/2006	EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006	EP1294757B1 Glucagon-like peptide-1 analogs
11/22/2006	EP1282444B1 Antithrombotic agents
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1194777B1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1146899B1 Methods of using neurotrophin 3 (nt-3) for the treatment of gastrointestinal hypomotility disorders
11/22/2006	EP1096924B1 Inhibitors of proteasomal activity for stimulating hair growth
11/22/2006	EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006	EP1071774B1 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
11/22/2006	EP1040120B1 Antifungal and antibacterial peptides
11/22/2006	EP1035131B1 Process for the preparation of n2 -(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline
11/22/2006	EP1015570B1 Fibrin microbeads and uses thereof
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0942925B1 Inhibitors of interleukin-1 beta converting enzyme
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	EP0783003B1 G-CSF TPO fusion proteins
11/22/2006	EP0574461B2 High affinity humanized monoclonal antibodies
11/22/2006	EP0512090B2 Treatment of inflammation
11/22/2006	CN1867673A NELL-1 enhanced bone mineralization
11/22/2006	CN1867669A Method for producing gamma-carboxylated proteins
11/22/2006	CN1867667A Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
11/22/2006	CN1867589A Synthetic polysaccharide antigens for immunological intervention in disease
11/22/2006	CN1867581A Il－21衍生物 Il-21 derivatives
11/22/2006	CN1867579A Novel peptidomimetic NS3-serine protease inhibitors of hepatitis c virus
11/22/2006	CN1867353A Use of LH for generating libido and reaching orgasm in female subjects
11/22/2006	CN1867352A Therapeutic uses of chemokine variants
11/22/2006	CN1867351A Remedy for kidney diseases
11/22/2006	CN1867350A Recombinant lubricin molecules and uses thereof
11/22/2006	CN1867349A Composition and method of treatment for urogenital conditions
11/22/2006	CN1867348A Orally administered small peptides synergize statin activity
11/22/2006	CN1867252A Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/22/2006	CN1865445A scFvC6.5-sTrail fusion gene and protein, and its preparation
11/22/2006	CN1865444A scFvC6.5-TNF-alpha fusion gene and protein, and its preparation
11/22/2006	CN1865286A Double function epidermal growth factor and its preparation method and uses
11/22/2006	CN1864822A Separating film for removing carbon monoxide, separating film assembly, method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide, oxygen carrier and its pha
11/22/2006	CN1864745A Method for improving Chinese herbal medicine efficacy for animals by utilizing cellulase
11/22/2006	CN1864744A Pharmaceutical preparation containing urate oxidase
11/22/2006	CN1864743A Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
11/22/2006	CN1864742A Transfer factor solution applied in livestock and poultry, its preparation method and application thereof
11/22/2006	CN1864677A An anti-thrombus anti-restenosis composite medicine coated on eluting stent
11/22/2006	CN1285724C 10-23 desoxyribonuclease of bacillus resisting tubercle branch
11/22/2006	CN1285610C Human liver regeneration promoting factor derivative and its expression
11/22/2006	CN1285607C Chinese hard tick neuropeptide and its preparing method and use
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285381C Chemokine mutants in treatment of multiple sclerosis
11/22/2006	CN1285288C Amylose, polypeptide functional blueberry drink and production process
11/21/2006	US7138569 Nucleic acids encoding pseudomonas hop proteins and use thereof
11/21/2006	US7138546 Compounds and compositions for delivering active agents
11/21/2006	US7138517 Sugar modified oligonucleotides
11/21/2006	US7138512 Gene SHINC-2 and diagnostic and therapeutic uses thereof
11/21/2006	US7138510 Cloning sequencing and characterization of two cell death genes and uses therefor
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138500 Antibodies to human 4-1BB
11/21/2006	US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily
11/21/2006	US7138498 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of
11/21/2006	US7138494 Comprises amino acid transport protein (ASC-1) for regulating NMDA-type glutamic acid receptor; treatment of nervous system disorders; antiproliferative agents; gene expression inhibition
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006	US7138491 3S-(2-Arg-Pro-Ala-Lys)-1,2,3,4,-tetrahydro-beta-carboline-3-carboxylic acid and 3S-(2-Pro-Ala-Lys)-1,2,3,4,-tetrahydro-beta-carboline-3-carboxylic acid
11/21/2006	US7138490 of polyethylene glycols and polylactams with an impurities content of not more than 10% by weight; complex of polymer and an anthracycline anticancer drug, such as doxorubicin
11/21/2006	US7138489 Method for producing a modified peptide
11/21/2006	US7138488 Viricides
11/21/2006	US7138487 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid
11/21/2006	US7138486 Insulinotropic hormone derivatives and uses thereof
11/21/2006	US7138419 Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
11/21/2006	US7138384 Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
11/21/2006	US7138382 Compositions and methods for drug delivery using pH sensitive molecules
11/21/2006	US7138381 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/2006	US7138379 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
11/21/2006	US7138378 Preparing a suppression effector and replacement nucleic acid that have modifications in one or more third base (wobble) positions so that replacement nucleic acids still code for the wild type or equivalent amino acids
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	US7138375 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs
11/21/2006	US7138374 Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137
11/21/2006	US7138373 Chitosan bound to residues of two or more polypeptides of different types, at least one which has a tyrosine residue; dressing wounds by administering the peptides, chitosan and a tyrosinase enzyme and allowing the chitosan to bind to the peptides
11/21/2006	US7138372 Comprises tumor necrosis factor
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138369 Compounds and methods for modulating apoptosis
11/21/2006	US7138276 Differentiation-suppressive polypeptide serrate-2 and methods of use
11/21/2006	US7138264 Unlike the native TACE catalytic domain, is stable at high protein concentrations; especially in crystal form complexed with a ligand such as [N-{3-(hydroxyaminocarbonyl)-1-oxo-(2R)-benzylpropyl}-Ile-Leu-OH
11/21/2006	US7138262 High mannose proteins and methods of making high mannose proteins
11/21/2006	US7138259 PDEs and uses thereof
11/21/2006	US7138251 Polynucleic acid molecule encoding receptors for glial cell line-derived neurotrophic factor
11/21/2006	US7138249 I dentifying modulators which alter binding of receptors and neuromedins for use in treatment of obesity, hypertension or stress-related diseases
11/21/2006	US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138236 Interactions of ATM, ATR or DAN-PK with p53

1 ... 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 ... 3163